DIVIDENDS RANKING

Highest Dividend yield of Pharmaceuticals and Biotechnology stocks




A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

01-31-2017

Dividend yield of Pharmaceuticals and Biotechnology companies ordered from highest ( 1.59% average).

Company Dividend Payout Country
AbbVie Inc4.19%74.64%USA
Teva Pharmaceutical4.15%55.59%Israel
Sanofi3.93%53.47%France
Takeda Pharm3.81%177.16%Japan
Novo-Nordisk B3.80%66.86%Denmark
Pfizer3.78%68.18%USA
Novartis (REGD)3.73%64.90%Switzerland
Roche Hldgs (GENUS)3.48%66.80%Switzerland
Bristol Myers Squibb3.17%148.57%USA
Merck & Co3.03%56.97%USA
Orion B3.01%87.25%Finland
Johnson & Johnson2.83%52.81%USA
Lilly (Eli) & Co2.65%74.18%USA
Gilead Sciences2.59%12.97%USA
Daiichi Sankyo2.57%43.69%Japan
Amgen Corp2.55%36.00%USA
Abbott Laboratories2.54%56.08%USA
Kaken Pharmaceutical2.50%27.75%Japan
Eisai2.41%17.11%Japan
KYORIN Holdings2.35%31.26%Japan
Sawai Pharmaceutical2.20%27.94%Japan
Astellas Pharmaceuti2.18%29.65%Japan
Miraca Holdings2.17%-125.43%Japan
Mitsubishi Tanabe Ph2.12%47.70%Japan
TORRENT PHARMACEUTIC2.02%23.63%India
Grifols S.A. Cl B1.97%43.06%Spain
Shanghai Pharmaceuti1.96%34.82%China
Tsumura & Co1.96%35.08%Japan
Otsuka Holdings1.92%64.32%Japan
Santen Pharm1.84%18.03%Japan
Alfresa Holdings1.83%21.05%Japan
China Traditional Ch1.75%31.58%China
UCB Cap1.73%43.31%Belgium and Lux.
China Medical System1.72%45.83%China
Mochida Pharm1.70%33.49%Japan
Ono Pharmaceutical1.65%75.75%Japan
Kyowa Hakko Kirin1.64%45.91%Japan
Medipal Holdings1.64%21.98%Japan
Kissei Pharm1.63%26.90%Japan
Grifols1.58%31.96%Spain
Chugai Seiyaku1.58%45.35%Japan
Wockhardt1.54%32.18%India
CSL1.48%43.12%Australia
Shanghai Fosun Pharm1.46%35.51%China
Suzuken1.45%17.98%Japan
Divis Laboratories1.43%23.88%India
Lonza Grp Ag N1.38%43.10%Switzerland
Hisamitsu Pharmaceut1.37%38.22%Japan
Sinopharm Group (H)1.35%29.45%China
Recordati1.33%32.11%Italy
Kalbe Farma1.31%43.64%Indonesia
Novozymes A/S1.30%31.36%Denmark
CSPC Pharmaceutical1.26%39.29%China
Chr. Hansen Holding1.25%44.12%Denmark
Shionogi1.25%31.50%Japan
Ipsen1.19%34.41%France
Richter1.17%20.47%Hungary
Taisho Pharmaceutica1.05%35.59%Japan
Piramal Enterprises1.04%27.35%India
Merck Kgaa1.03%21.69%Germany
Rohto Pharmaceutical1.02%23.87%Japan
Yuhan1.01%16.06%Korea
Sino Biopharm (P Chi0.98%25.00%China
Kobayashi Pharmaceut0.95%28.22%Japan
Sumitomo Dainippon P0.95%23.47%Japan
Cadila Healthcare0.91%21.11%India
Hanmi Science0.87%15.75%Korea
China National Accor0.81%14.23%China
Aspen Pharmacare Hol0.81%23.12%South Africa
Perrigo Company plc0.76%10.21%USA
Zoetis0.76%45.16%USA
Luye Pharma Group (P0.72%14.29%China
Hanmi Pharmaceutical0.69%11.66%Korea
Dr Reddys Labs0.66%14.38%India
Actelion Hldg N0.58%25.51%Switzerland
Nippon Shinyaku0.55%34.16%Japan
Lupin0.51%14.48%India
Aurobindo Pharmaceut0.39%7.65%India
Cipla0.35%10.48%India
Glenmark Pharmaceuti0.22%6.59%India
Sun Pharmaceuticals0.16%4.91%India
Qiagen Nv0.00%0.00%Germany
Valeant Pharmaceutic0.00%0.00%Canada
3SBio (P Chip)0.00%0.00%China
Guangzhou Baiyunsha0.00%0.00%China
Genmab0.00%0.00%Denmark
H. Lundbeck0.00%0.00%Denmark
Peptidream0.00%0.00%Japan
Celltrion Inc0.00%0.00%Korea
Samsung Biologics0.00%0.00%Korea
OBI Pharma0.00%0.00%Taiwan
AstraZeneca0.00%0.00%UK
GlaxoSmithKline0.00%0.00%UK
Hikma Pharmaceutical0.00%0.00%UK
Shire0.00%0.00%UK
Alexion Pharm0.00%0.00%USA
Alkermes plc0.00%0.00%USA
Allergan0.00%0.00%USA
Alnylam Pharmaceutic0.00%0.00%USA
Biogen0.00%0.00%USA
BioMarin Pharm0.00%0.00%USA
Celgene Corp0.00%0.00%USA
Endo International p0.00%0.00%USA
Illumina Inc0.00%0.00%USA
Incyte0.00%0.00%USA
Jazz Pharmaceuticals0.00%0.00%USA
Mallinckrodt plc0.00%0.00%USA
Mylan N.V.0.00%0.00%USA
Quintiles Transnatio0.00%0.00%USA
Regeneron Phar0.00%0.00%USA
Vertex Pharm0.00%0.00%USA
Medivation0.00%0.00%USA
Adcock Ingram Holdin2.74%88.51%South Africa
Meda A1.57%21.55%Sweden
GlaxoSmithKline Phar1.51%111.59%India

 


 

All rights reserved

 information advertisement legal

Dividends Ranking | Firm Report | Price to BookValue | Price to Cash-Flow | Price to Earnings | Return on Equity

Part of Enciclopedia Financiera Group

Disclaimer: Information on this site is only for informational purposes. Always consult a professional advisor before investing.